Abbott | ABT - Les Charges D'Exploitation

Prix De L'Action
84.47
Variation Quotidienne
-0.43 -0.51%
Mensuellement
-11.52%
Annuel
-37.34%
Q2 Prévisions
82.77




Les Charges D'Exploitation Changement Date
Abbott USD 9.31B 104M 2026-03
Agilent USD 1.44B 27M 2025-12
AtriCure USD 140.72M 2.71M 2026-03
Baxter International USD 6.04B 2.85B 2026-03
Becton, Dickinson and Co. USD 24.13B 19.54B 2026-03
Bio-Rad Laboratories USD 6.85B 6.21B 2026-03
Boston Scientific USD 4.15B 107M 2026-03
Cooper Companies USD 811.3M 113.5M 2025-12
Danaher USD 52.95B 47.61B 2026-03
Dexcom USD 936.6M 0 2026-03
Edwards Lifesciences USD 1.13B 65.4M 2026-03
Globus Medical USD 595.85M 49.26M 2026-03
Insulet USD 639.7M 2.2M 2026-03
Integra LifeSciences USD 1.04B 673.49M 2026-03
Intuitive Surgical USD 1.91B 89.8M 2026-03
J&J USD 17.44B 1.53B 2026-03
Masimo USD 326.2M 2.4M 2026-03
Medtronic USD 7.28B 16M 2025-12
Merit Medical Systems USD 337.72M 2.02M 2026-03
Pfizer USD 90.1B 77.19B 2026-03
Smith & Nephew USD 2.52B 84M 2025-12
Solventum Corp USD 4.97B 3.08B 2026-03
Stryker USD 4.92B 284M 2026-03
Tandem Diabetes Care USD 282.09M 9.97M 2025-12
Teleflex USD 3.08B 2.55B 2026-03
Terumo JPY 252.74B 22.88B 2025-12
Thermo Fisher Scientific USD 9.09B 821M 2026-03
Zimmer Biomet Holdings USD 1.69B 249.3M 2026-03